Aspiriant LLC’s iShares Russell 2000 Growth ETF IWO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.14M | Sell |
3,634
-132
| -4% | -$43.9K | 0.03% | 147 |
|
|
2025
Q4 | $1.22M | Buy |
3,766
+320
| +9% | +$104K | 0.03% | 148 |
|
|
2025
Q3 | $1.1M | Sell |
3,446
-58
| -2% | -$17.5K | 0.03% | 139 |
|
|
2025
Q2 | $1M | Buy |
3,504
+18
| +0.5% | +$4.74K | 0.03% | 147 |
|
|
2025
Q1 | $891K | Hold |
3,486
| – | – | 0.03% | 146 |
|
|
2024
Q4 | $1M | Buy |
3,486
+14
| +0.4% | +$4.14K | 0.04% | 143 |
|
|
2024
Q3 | $986K | Buy |
3,472
+20
| +0.6% | +$5.48K | 0.04% | 147 |
|
|
2024
Q2 | $906K | Buy |
3,452
+448
| +15% | +$116K | 0.04% | 146 |
|
|
2024
Q1 | $813K | Hold |
3,004
| – | – | 0.03% | 156 |
|
|
2023
Q4 | $758K | Buy |
3,004
+30
| +1% | +$6.76K | 0.03% | 161 |
|
|
2023
Q3 | $667K | Sell |
2,974
-49
| -2% | -$11.7K | 0.03% | 159 |
|
|
2023
Q2 | $734K | Buy |
3,023
+102
| +3% | +$23.4K | 0.04% | 156 |
|
|
2023
Q1 | $663K | Hold |
2,921
| – | – | 0.03% | 157 |
|
|
2022
Q4 | $627K | Buy |
2,921
+91
| +3% | +$19.9K | 0.03% | 163 |
|
|
2022
Q3 | $583K | Hold |
2,830
| – | – | 0.03% | 156 |
|
|
2022
Q2 | $582K | Buy |
2,830
+144
| +5% | +$32.1K | 0.03% | 155 |
|
|
2022
Q1 | $687K | Buy |
2,686
+216
| +9% | +$55.3K | 0.04% | 153 |
|
|
2021
Q4 | $723K | Hold |
2,470
| – | – | 0.04% | 160 |
|
|
2021
Q3 | $725K | Hold |
2,470
| – | – | 0.04% | 137 |
|
|
2021
Q2 | $770K | Hold |
2,470
| – | – | 0.04% | 132 |
|
|
2021
Q1 | $742K | Hold |
2,470
| – | – | 0.05% | 123 |
|
|
2020
Q4 | $708K | Hold |
2,470
| – | – | 0.05% | 131 |
|
|
2020
Q3 | $547K | Hold |
2,470
| – | – | 0.04% | 145 |
|
|
2020
Q2 | $511K | Sell |
2,470
-5,025
| -67% | -$940K | 0.05% | 127 |
|
|
2020
Q1 | $1.19M | Buy |
7,495
+5,025
| +203% | +$998K | 0.12% | 69 |
|
|
2019
Q4 | $530K | Hold |
2,470
| – | – | 0.05% | 132 |
|
|
2019
Q3 | $476K | Hold |
2,470
| – | – | 0.04% | 151 |
|
|
2019
Q2 | $497K | Hold |
2,470
| – | – | 0.04% | 150 |
|
|
2019
Q1 | $486K | Hold |
2,470
| – | – | 0.04% | 146 |
|
|
2018
Q4 | $415K | Hold |
2,470
| – | – | 0.03% | 153 |
|
|
2018
Q3 | $531K | Hold |
2,470
| – | – | 0.05% | 150 |
|
|
2018
Q2 | $505K | Buy |
+2,470
| New | +$494K | 0.04% | 158 |
|
|
2017
Q2 | – | Sell |
-1,415
| Closed | -$229K | – | 221 |
|
|
2017
Q1 | $229K | Buy |
+1,415
| New | +$225K | 0.02% | 194 |
|
|
2016
Q1 | – | Sell |
-1,590
| Closed | -$221K | – | 171 |
|
|
2015
Q4 | $221K | Sell |
1,590
-2,130
| -57% | -$302K | 0.02% | 74 |
|
|
2015
Q3 | $498K | Sell |
3,720
-434
| -10% | -$64.3K | 0.04% | 70 |
|
|
2015
Q2 | $642K | Sell |
4,154
-1,777
| -30% | -$272K | 0.06% | 62 |
|
|
2015
Q1 | $899K | Sell |
5,931
-851
| -13% | -$124K | 0.12% | 43 |
|
|
2014
Q4 | $966K | Hold |
6,782
| – | – | 0.13% | 38 |
|
|
2014
Q3 | $880K | Sell |
6,782
-430
| -6% | -$57.6K | 0.12% | 38 |
|
|
2014
Q2 | $998K | Hold |
7,212
| – | – | 0.14% | 45 |
|
|
2014
Q1 | $981K | Sell |
7,212
-727
| -9% | -$99.4K | 0.14% | 51 |
|
|
2013
Q4 | $1.08M | Buy |
+7,939
| New | +$1.03M | 0.17% | 39 |
|
|
2013
Q3 | – | Sell |
-7,939
| Closed | -$885K | – | 58 |
|
|
2013
Q2 | $885K | Buy |
+7,939
| New | +$867K | 0.14% | 35 |
|
Other funds holding IWO
B
CCWM
TCIIS
Aspiriant LLC's IWO Position: Q1 2026 in Review
Aspiriant LLC reduced its iShares Russell 2000 Growth ETF (IWO) stake by 3.5% in Q1 2026, selling an estimated $43.9K and leaving 3,634 shares worth $1.14M. The position accounts for 0.03% of the portfolio, ranked #147.
Aspiriant LLC first reported a position in IWO in Q2 2013 and has held it in 43 quarters since. The position peaked at $1.22M in Q4 2025. 1,019 funds tracked by Wall St. Rank hold IWO as of Q1 2026.
- Aspiriant LLC held 3,634 shares of iShares Russell 2000 Growth ETF worth $1.14M as of Q1 2026.
- Aspiriant LLC sold 132 iShares Russell 2000 Growth ETF shares in Q1 2026, an estimated $43.9K.
- iShares Russell 2000 Growth ETF made up 0.03% of Aspiriant LLC's portfolio in Q1 2026, its #147 holding.
- Aspiriant LLC first reported a position in iShares Russell 2000 Growth ETF in Q2 2013 and has held it in 43 quarters since.
- Aspiriant LLC's iShares Russell 2000 Growth ETF position peaked at $1.22M in Q4 2025.
- 1,019 funds tracked by Wall St. Rank held iShares Russell 2000 Growth ETF as of Q1 2026.
Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.